German Drugmaker Stada Is Pushing Back IPO Until September
Stada Arzneimittel AG’s private equity owners are pushing back a planned initial public offering of the German drugmaker ...
Germany's Stada Postpones IPO Until September, Bloomberg Says, Citing Sources
--Stada's listing plans are still being discussed and subject to change, according to Bloomberg. JPMorgan Chase, Morgan Stanley, Deutsche Bank, and Goldman Sachs are leading the Stada IPO as global ...
Bloomberg L.P.5d
German Drugmaker Stada Is Pushing Back IPO Until September
Stada Arzneimittel AG’s private equity owners are pushing back a planned initial public offering of the German drugmaker until September, people with knowledge of the matter said. Bain Capital ...
H&F Picks Goldman Sachs, Morgan Stanley for Verisure IPO
Private equity firm Hellman & Friedman has selected banks to lead the initial public offering of security group Verisure, ...
US Backlog Pushes European Unicorns to Eye Local IPOs, Citi Says
A backlog of US technology listings may lead some of Europe’s top homegrown candidates to pursue public offerings on local ...
Verisure IPO: PE firm H&F picks Goldman, Morgan Stanley for one of Europe’s largest public offers
Hellman & Friedman has selected Goldman Sachs and Morgan Stanley to lead the IPO of security firm Verisure, potentially ...
Buyout Firm CVC Eyes US Private Credit in Expansion Drive
The private equity owners of Stada Arzneimittel AG have decided to push back the German drugmaker’s IPO until September, Bloomberg News reported this week. German regional lender Oldenburgische ...
PipelineReview.com3d
Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production
REYKJAVIK, Iceland and STOCKHOLM, Sweden I March 20, 2025 I Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture ...
Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...